Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Search Results
8 results
Filters applied: . Clear all
Results are displayed in a computed author sort order.
The Results By Year timeline is not available.
Page 1
FVIII-binding IgG modulates FVIII half-life in patients with severe and moderate hemophilia A without inhibitors.
Blood. 2016 Jul 14;128(2):293-6. doi: 10.1182/blood-2015-10-675512. Epub 2016 May 23.
Blood. 2016.
PMID: 27216215
Free article.
Distinct characteristics of antibody responses against factor VIII in healthy individuals and in different cohorts of hemophilia A patients.
Whelan SF, Hofbauer CJ, Horling FM, Allacher P, Wolfsegger MJ, Oldenburg J, Male C, Windyga J, Tiede A, Schwarz HP, Scheiflinger F, Reipert BM.
Whelan SF, et al. Among authors: hofbauer cj.
Blood. 2013 Feb 7;121(6):1039-48. doi: 10.1182/blood-2012-07-444877. Epub 2012 Dec 12.
Blood. 2013.
PMID: 23243272
Free article.
Item in Clipboard
Affinity of FVIII-specific antibodies reveals major differences between neutralizing and nonneutralizing antibodies in humans.
Hofbauer CJ, Whelan SF, Hirschler M, Allacher P, Horling FM, Lawo JP, Oldenburg J, Tiede A, Male C, Windyga J, Greinacher A, Knöbl PN, Schrenk G, Koehn J, Scheiflinger F, Reipert BM.
Hofbauer CJ, et al.
Blood. 2015 Feb 12;125(7):1180-8. doi: 10.1182/blood-2014-09-598268. Epub 2014 Dec 16.
Blood. 2015.
PMID: 25515962
Free article.
Item in Clipboard
Anti-factor VIII IgA as a potential marker of poor prognosis in acquired hemophilia A: results from the GTH-AH 01/2010 study.
Tiede A, Hofbauer CJ, Werwitzke S, Knöbl P, Gottstein S, Scharf RE, Heinz J, Groß J, Holstein K, Dobbelstein C, Scheiflinger F, Koch A, Reipert BM.
Tiede A, et al. Among authors: hofbauer cj.
Blood. 2016 May 12;127(19):2289-97. doi: 10.1182/blood-2015-09-672774. Epub 2016 Feb 24.
Blood. 2016.
PMID: 26912467
Free article.
Clinical Trial.
Item in Clipboard
The prospective Hemophilia Inhibitor PUP Study reveals distinct antibody signatures prior to FVIII inhibitor development.
Reipert BM, Gangadharan B, Hofbauer CJ, Berg V, Schweiger H, Bowen J, Blatny J, Fijnvandraat K, Mullins ES, Klintman J, Male C, McGuinn C, Meeks SL, Radulescu VC, Ragni MV, Recht M, Shapiro AD, Staber JM, Yaish HM, Santagostino E, Brown DL.
Reipert BM, et al. Among authors: hofbauer cj.
Blood Adv. 2020 Nov 24;4(22):5785-5796. doi: 10.1182/bloodadvances.2020002731.
Blood Adv. 2020.
PMID: 33232473
Free PMC article.
Item in Clipboard
Nonneutralizing FVIII-specific antibody signatures in patients with hemophilia A and in healthy donors.
Schweiger H, Rejtő J, Hofbauer CJ, Berg V, Allacher P, Zwiauer K, Feistritzer C, Schuster G, Ay C, Reipert BM, Pabinger I.
Schweiger H, et al. Among authors: hofbauer cj.
Blood Adv. 2022 Feb 8;6(3):946-958. doi: 10.1182/bloodadvances.2021005745.
Blood Adv. 2022.
PMID: 34847225
Free PMC article.
Item in Clipboard
Qualification of Hemophilia Treatment Centers to Enable Multi-Center Studies of Gene Expression Signatures in Blood Cells from Pediatric Patients.
Reipert BM, Hofbauer CJ, Gangadharan B, Berg V, Donnachie E, Meeks S, Mancuso ME, Bowen J, Brown DL.
Reipert BM, et al. Among authors: hofbauer cj.
J Clin Med. 2023 Mar 6;12(5):2080. doi: 10.3390/jcm12052080.
J Clin Med. 2023.
PMID: 36902866
Free PMC article.
Item in Clipboard
The Viral Gene ORF79 Encodes a Repressor Regulating Induction of the Lytic Life Cycle in the Haloalkaliphilic Virus ϕCh1.
Selb R, Derntl C, Klein R, Alte B, Hofbauer C, Kaufmann M, Beraha J, Schöner L, Witte A.
Selb R, et al.
J Virol. 2017 Apr 13;91(9):e00206-17. doi: 10.1128/JVI.00206-17. Print 2017 May 1.
J Virol. 2017.
PMID: 28202757
Free PMC article.
Item in Clipboard
Cite
Cite